✦ LIBER ✦

Response as an end point in treatment trials for acute GVHD

✍ Scribed by Pavletic, S Z

Book ID: 111925270
Publisher: Nature Publishing Group
Year: 2012
Tongue: English
Weight: 335 KB
Volume: 47
Category: Article
ISSN: 0007-1188
DOI: 10.1038/bmt.2011.59

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Imaging as an End Point in Ischemia Tria

Imaging as an End Point in Ischemia Trials

✍ Andrew G. Howarth; Matthias G. Friedrich 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 184 KB

Imaging of cardiac function and anatomy has advanced at an exponential rate over the past two decades. Our ability to quantitatively assess the degree of myocardial ischemia and accurately define the vascular anatomy using noninvasive techniques is greater than ever before. Current advances is cardi

Dyspnea as an end point in clinical tria

Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure

✍ John R. Teerlink 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Exercise as an end-point in pulmonary hy

Exercise as an end-point in pulmonary hypertension trials

✍ B. McCullagh; R. E. Girgis 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Characterization of Myocardial Infarctio

Characterization of Myocardial Infarction as an End Point in Two Large Trials of Acute Coronary Syndromes

✍ Kenneth W. Mahaffey; Matthew T. Roe; Rakhi Kilaru; John K. French; John H. Alexa 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 149 KB

End Points for Clinical Trials in Acute

End Points for Clinical Trials in Acute Heart Failure Syndromes

✍ Larry A. Allen; Adrian F. Hernandez; Christopher M. O'Connor; G. Michael Felker 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 473 KB

Progression-free survival as an end-poin

Progression-free survival as an end-point in clinical trials of biotherapeutic agents

✍ Lothar Bergmann; Steven Hirschfeld; Charles Morris; Sergio Palmeri; Andrew Stone 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 141 KB